Federal Panel Recommends Approving New Cholesterol Drug
An advisory panel to the F.D.A. recommended approving alirocumab, which drastically reduces LDL cholesterol levels and could protect against heart attacks.
Continue Reading
An advisory panel to the F.D.A. recommended approving alirocumab, which drastically reduces LDL cholesterol levels and could protect against heart attacks.
Continue Reading
Join the Discussion